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The TrkB-Shc Site Signals Neuronal
Survival and Local Axon Growth
via MEK and PI3-Kinase
their preferred ligands, transphosphorylate key tyrosine
residues within the receptor's intracellular domain, which
serve as a scaffold to which various signaling proteins
are recruited and activated (Segal and Greenberg, 1996;
Kaplan and Miller, 2000). In primary rat sympathetic and
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sensory neurons, TrkA stimulates neuronal survival byMcGill University
the Ras/PI3-kinase/Akt signal transduction pathwayMontreal, Quebec H3A 2B4
(Kaplan and Miller, 2000). Inhibition of Ras, PI3-kinase,Canada
or Akt activity using function-blocking antibodies, domi-³Biotechnology Research Institute
nant-inhibitory mutants, or pharmacological inhibitors
Montreal, Quebec H4P 2R2
all suppress NGF-mediated survival (Kaplan and Miller,
Canada 2000). Several signaling proteins may link Trk signals
to Ras, including Shc, Gab1, FRS-2, rAPS, and SH2-B
(Kaplan and Miller, 2000). These proteins also contribute
Summary to Trk's ability to activate PI3-kinase and Akt, and MEK
and ERK, the latter of which mediate PC12 cell re-
To determine how signals emanating from Trk transmit sponses to NGF (Cowley et al., 1994; Pang et al., 1995)
neurotrophin actions in primary neurons, we tested but whose role is still undefined in neurotrophin signaling
in peripheral neurons.the ability of TrkB mutated at defined effector binding
Studies examining Trk survival and growth signalssites to promote sympathetic neuron survival or local
have utilized Trk receptors mutated at sites required foraxon growth. TrkB stimulated signaling proteins and
coupling Trk to the Ras, PI3-kinase/Akt, MEK/ERK, andinduced survival and growth in a manner similar to
PLC-g1 signal transduction pathways (Figure 1A). ForTrkA. TrkB mutated at the Shc binding site supported
example, tyrosine 490 is essential for association of Trksurvival and growth poorly relative to wild-type TrkB,
with the phosphotyrosine binding (PTB) domains of Shcwhereas TrkB mutated at the PLC-g1 binding site sup-
and FRS2 (Stephens et al., 1994; Meakin et al., 1999).ported growth and survival well. TrkB-mediated neu-
Shc binding to Trk subsequently leads to activation ofronal survival was dependent on PI3-kinase and to a
Ras, Raf, MEK, ERK, and PI3-kinase (Kaplan and Miller,lesser extent MEK activity, while growth depended
2000). Tyrosine 785 similarly recruits PLC-g1 to acti-upon both MEK and PI3-kinase activities. These re-
vated Trk, leading to activation of PLC-g1 itself (Loeb
sults indicate that the TrkB-Shc site mediates both et al., 1994; Middlemas et al., 1994). Combined mutation
neuronal survival and axonal outgrowth by activating of the Shc and PLC-g1 binding sites abrogates Trk's
the PI3-kinase and MEK signaling pathways. ability to promote neurite outgrowth and PI3-kinase, Akt,
and ERK activity in PC12 cells (Obermeier et al., 1994;
Introduction Stephens et al., 1994; Ashcroft et al., 1999). Two studies
have used these Trk mutants to assess neurotrophin-
During development, peripheral neurons extend their ax- mediated signal transduction in vivo and in primary neu-
ons to defined targets, and upon reaching those targets, rons. Mice which express TrkB lacking the Shc site show
become absolutely dependent upon limiting amounts severely compromised survival of NT-4-dependent sen-
of target-derived trophic factors such as nerve growth sory neurons, with milder effects on BDNF-dependent
factor (NGF) (Henderson, 1996). Target-derived NGF populations (Minichiello et al., 1998). In contrast, Xeno-
acts via its axonal receptors to (a) retrogradely deter- pus spinal neurons expressing TrkA receptors mutated
mine neuronal survival and (b) locally regulate axon at either the PLC-g or a putative PI3-kinase binding site
growth and thereby determine the density of target in- showed defects in growth cone guidance (Ming et al.,
nervation. Increasing evidence indicates that, at least 1999).
for peripheral sympathetic neurons, the survival signal In the present study, we address how Trk receptors
involves retrograde trafficking and/or activation of Trk are coupled to downstream signal transduction path-
receptors (Bhattacharyya et al., 1997; Riccio et al., 1997; ways in primary sympathetic neurons, and ask which of
Senger and Campenot, 1997) and subsequent activation these pathways are required to mediate neurotrophin-
of the Ras/PI3-kinase/Akt pathway (Kaplan and Miller, dependent neuronal survival and local axonal growth.
2000). However, the nature of the local signals that pro- To address this issue, we examine the survival and local
mote terminal growth and target innervation in response growth signals derived from Trk receptors using culture
to NGF remain undefined, although it is clear that these systems where these two responses can be indepen-
local events require TrkA signaling (Fagan et al., 1996; dently manipulated. We use an adenovirus vector-based
Patel et al., 2000). Furthermore, the mechanisms by approach to facilitate efficient expression of signaling
which activated Trk receptors coordinate intracellular proteins in postmitotic sympathetic neurons, and the
signaling cascades to mediate survival and growth are culture of neurons in compartmented chambers to allow
still relatively ill defined, although recent reports have for the quantification of the rate and extent of axon
identified several survival signals in peripheral neurons. growth in a system that separates the effects of neuro-
Similar to other RTKs, Trk receptors, when bound by trophins on local axonal growth from their effects on
cell survival. We used cultured neonatal rat sympathetic
neurons, which others and we have previously de-§ To whom correspondence should be addressed (e-mail: mcdv@
musica.mcgill.ca). scribed as dependent on NGF and TrkA for growth and
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Figure 1. Detection of Recombinant Adeno-
virus-Expressed TrkB in Sympathetic Neurons
SCG neurons cultured for 4 days were in-
fected overnight with 200 MOI of WT TrkB
adenovirus and assessed for expression 48
hr later.
(A) Schematic diagram of the TrkB receptor,
indicating mutated sites.
(B) Immunostaining for the c-Myc epitope
reveals TrkB expression throughout cell bod-
ies and neurites of infected cells. Scale bar 5
20 mm.
(C) Infected cells were lysed and 300 mg of
protein immunoprecipitated with pan-Trk an-
tibody (203). Immunoprecipitated proteins
were separated by SDS±PAGE and analyzed
by Western blot with anti-c-Myc. c-Myc-
tagged TrkB is detected only in infected cells.
(D) Expression of functional TrkB following
addition of BDNF. Infected cells were treated
with medium alone (Control), 50 ng/ml NGF,
or 100 ng/ml BDNF for 10 min, lysed, and
200 mg protein immunoprecipitated with anti-
pan-Trk (203). Immunoprecipitated proteins
were analyzed by SDS±PAGE and probed
with phosphotyrosine antibody (4G10) to re-
veal receptor activation. TrkB was activated
specifically in the presence of BDNF.
survival (Chun and Patterson, 1977; Greene, 1977; Belli- including wild-type TrkB (WT TrkB), TrkB mutated at
Tyr-490 (Y490F), which is the Shc and FRS-2 bindingveau et al., 1997). To characterize the signaling pro-
cesses regulated by Trk, we studied the biological and site (TrkB Shc2), TrkB mutated at Tyr-785 (Y785F), which
is the PLC-g1 binding site (TrkB PLC-g12), TrkB encod-signaling responses of exogenously expressed TrkB,
which has 90% similarity to TrkA within the kinase do- ing combined mutations of the Shc and PLC-g1 binding
main and which is not endogenously expressed by sym- sites (TrkB Shc2/PLC-g12), TrkB mutated in the SNT-
pathetic neurons (Belliveau et al., 1997). While the TrkB activation domain (TrkB DKGF), and an inactive TrkB
ligand BDNF normally suppresses sympathetic neuron receptor mutated at its ATP binding site (K538N, kinase
survival and axonal growth by activating the p75NTR, dead TrkB). All of the mutations were either based upon
expression of TrkB converts BDNF into a prosurvival data from TrkB mutagenesis studies or were designed
and growth ligand for these neurons. BDNF and TrkB based on the high homology of consensus sites in TrkB
therefore act much like NGF and TrkA, effectively sup- to TrkA, where analogous mutations have been pre-
pressing p75 apoptotic and growth inhibitory signaling. viously described (Loeb et al., 1994; Middlemas et al.,
TrkB-mediated survival responses were transduced by 1994; Stephens et al., 1994; Peng et al., 1995; Minichiello
the Shc association site of TrkB and subsequent acti- et al., 1998; McCarty and Feinstein, 1999).
vation of PI3-kinase and to some extent MEK. TrkB- The TrkB viruses described above were used to infect
induced local axonal growth was also dependent upon primary cultures of neonatal rat sympathetic neurons.
the integrity of the Shc association site and on MEK and Neurons infected for 3 days with recombinant adenovi-
PI3-kinase activity. These results identify PI3-kinase and rus were analyzed for TrkB expression by immunostain-
MEK as proteins that work in concert to regulate local ing and Western blotting. The viruses efficiently infected
axonal growth in mammalian peripheral neurons. primary sympathetic neurons, resulting in TrkB receptor
expression throughout cell bodies and processes (Fig-
Results ure 1B), as assessed by immunostaining with an anti-
body that reacts with the c-Myc epitope tag on TrkB. A
multiplicity of infection (MOI) of 200 transduced mostGeneration and Expression of TrkB Adenoviruses
A series of recombinant adenoviruses expressing full- neurons while exhibiting little toxicity (80%±90% sur-
vival up to 5 days postinfection). Furthermore, infectionlength c-Myc-tagged TrkB receptors were generated,
TrkB Survival and Axon Growth Signals
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Figure 2. Expression and Activation of TrkB
Receptor Mutants in Sympathetic Neurons
Sister cultures of SCG neurons were infected
overnight with 200 MOI of adenovirus ex-
pressing WT TrkB or the different mutant TrkB
receptors. Forty-eight hours later, cells were
lysed immediately (A) or following 10 min
stimulation with medium alone (Control), 50
ng/ml NGF, or 100 ng/ml BDNF (B±D).
(A) Three hundred micrograms of protein ly-
sates were immunoprecipitated with anti-
pan-Trk (203) and analyzed by Western blot-
ting using anti-c-Myc. All infected cells
showed similar levels of c-Myc-tagged TrkB
receptor expression.
(B) Ligand-induced Trk tyrosine phosphoryla-
tion was evaluated by immunoprecipitating
200 mg protein with pan-Trk antibody (203)
and examining immunoprecipitated proteins
by Western blot analysis performed with anti-
phosphotyrosine (4G10). TrkB receptors were
phosphorylated to approximately equivalent
levels and similarly to TrkA; kinase dead TrkB
was not phosphorylated.
(C) Shc tyrosine phosphorylation was as-
sessed by immunoprecipitating 200 mg of ly-
sate from stimulated neurons with Shc anti-
body and analyzing by Western blot, probing
with phosphotyrosine antibody. Shc was
strongly tyrosine phosphorylated by either
stimulation of TrkA by NGF or WT TrkB by
BDNF. However, BDNF-mediated activation
of TrkB Shc2 and TrkB Shc2/PLC-g12 did not
lead to Shc phosphorylation. Tyrosine-phos-
phorylated Trk receptors coprecipitated with
active Shc. Bottom panel shows the same
blot reprobed with an antibody that recog-
nizes total Shc protein.
(D) PLC-g1 tyrosine phosphorylation was as-
sessed by immunoprecipitating 200 mg of
stimulated lysate with PLC-g1 antibody and
probing Western blots with anti-phosphotyrosine. PLC-g1 was tyrosine phosphorylated by both TrkA (with NGF) and WT TrkB (with BDNF)
but not by TrkB PLC-g12 or TrkB Shc2/PLC-g12 (with BDNF). Activated Trk receptors coimmunoprecipitated with tyrosine-phosphorylated
PLC-g1. Bottom panel shows the same blot reprobed with an antibody that recognizes total PLC-g1.
of sympathetic neurons with adenovirus expressing WT We next examined the ability of the TrkB receptors
TrkB resulted in expression of 145 kDa TrkB (Figure 1C), to tyrosine phosphorylate and associate with the major
as assessed by Western blot analysis with anti-c-Myc. Trk interacting proteins, Shc and PLCg1. To compare
TrkB was activated by BDNF and not NGF, as deter- the signaling potential of TrkB to that of endogenous
mined by tyrosine phosphorylation of the receptor (Fig- TrkA, sister cultures were infected with WT TrkB or TrkB
ure 1D, and data not shown). Moreover, immunoprecipi- mutants and exposed to NGF or BDNF. We first as-
tation with TrkA-specific antibodies confirmed that there sessed tyrosine phosphorylation of the adaptor protein
was no cross-activation of endogenous TrkA by BDNF Shc, which directly binds to and becomes tyrosine phos-
or BDNF-activated TrkB (data not shown). phorylated by activated Trk (Stephens et al., 1994).
BDNF-mediated TrkB activation induced the tyrosine
phosphorylation of the major ShcA isoform, p68Shc, asTyrosine Phosphorylation of SHC and PLCg1 by TrkB
did NGF activation of TrkA (Figure 2C). As predicted,Receptors in Sympathetic Neurons
Shc tyrosine phosphorylation was not seen upon stimu-The adenoviruses encoding TrkB mutants also effi-
lation of the TrkB Shc2 or TrkB Shc2/PLC-g12 mutants.ciently transduced sympathetic neurons. Western blot
In all cases where Shc was tyrosine phosphorylated,analysis with anti-c-Myc indicated that all TrkB mutants
Shc also coimmunoprecipitated with Trk receptors (Fig-were expressed at similar levels (Figure 2A). Further-
ure 2C). PLC-g1 was also tyrosine phosphorylated uponmore, all TrkB receptors except for the kinase dead TrkB
BDNF-induced activation of wild-type TrkB, similar tomutant were activated by BDNF, as demonstrated by
the levels observed upon NGF-mediated activation ofdetection of TrkB tyrosine phosphorylation (Figure 2B).
endogenous TrkA (Figure 2D). This phosphorylation wasIn all cases, receptor activation was ligand dependent
not mediated by TrkB PLC-g12 or TrkB Shc2/PLC-g12.(data not shown). The level of TrkB activation at 100 ng/
TrkB also coimmunoprecipitated with tyrosine-phos-ml BDNF was similar to the level of endogenous TrkA
phorylated PLC-g1 (Figure 2D).activation by 50 ng/ml NGF, suggesting that TrkB was
We examined the ability of TrkB and the TrkB mutantsexpressed at slightly lower than but comparable levels
to endogenous TrkA. to stimulate tyrosine phosphorylation of SNT, as de-
Neuron
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Figure 3. Phosphorylation of ERK1/2 and Akt
by Adenovirus-Expressed TrkB
Cultured SCG neurons infected with 200 MOI
of WT TrkB or different TrkB receptor mutants
were stimulated for 10 min (A and B) or 12
hr (C) with medium alone (Control), 50 ng/ml
NGF, or 100 ng/ml BDNF and then lysed. Fifty
micrograms of total cell lysate was analyzed
by Western blot, probing for phospho-ERK
(A and C, top panel) or phospho-Akt (B and
C, bottom panel).
(A) Activation of ERK1 and ERK2 was de-
tected using a phospho (Thr-183/Tyr-185)±
specific ERK antibody. NGF/TrkA and BDNF/
TrkB activated ERK similarly, whereas TrkB
Shc2 yielded z50% activation, and TrkB
Shc2/PLC-g12 gave minimal activation. Bot-
tom panel shows a reprobe of the same blot
with an ERK1 antibody.
(B) Activation of Akt was detected using a
phospho (Ser-473)±specific Akt antibody.
TrkA and TrkB induce similar phosphorylation
of Akt. The TrkB Shc2 or TrkB Shc2/PLC-g12
mutants show greatly reduced Akt phosphor-
ylation. Bottom panel shows the same blot
reprobed for total Akt.
(C) Regulation by Ras of TrkB-mediated activation of ERK1/2 (top panels) and Akt (bottom panels) was assessed by coinfecting cells with
adenovirus expressing the TrkB constructs and dominant-negative (DN) Ras (100 MOI). DN Ras suppressed a significant portion of ERK and
Akt activation by TrkA, WT TrkB, and the TrkB mutants. The lower blot in each panel shows a reprobe of the upper blots for total ERK1 (upper)
or Akt (lower) protein.
scribed by Peng et al. (1995). Whereas TrkB induced kinase Akt in response to neurotrophin stimulation of
sympathetic neurons. Akt is an effector of the PI3-kinasethe phosphorylation of a protein corresponding to SNT,
pathway that is activated by NGF in sympathetic neu-none of the mutants, including TrkB DKGF, were defi-
rons and is responsible for the majority of NGF-pro-cient in activation of this protein (data not shown). Thus,
moted survival in these cells (Crowder and Freeman,as far as we can assess, TrkB DKGF serves as a positive
1998; Vaillant et al., 1999). Akt activation was analyzedcontrol rather than a mutant in our experiments.
indirectly by immunoblotting with a phosphorylation-
specific Akt antibody, a direct correlate of Akt kinaseMAP Kinase and AKT Phosphorylation Are
activity in sympathetic neurons (Vaillant et al., 1999). AktStimulated by Both TrkA and TrkB
phosphorylation was robustly increased upon ligand-To examine stimulation of signaling cascades further
mediated stimulation of either TrkA or TrkB after 10 mindownstream of TrkB, we assessed activation of the MAP
(Figure 3B) or 24 hr (data not shown). Disruption of thekinases ERK1 and ERK2. These kinases have previously
Shc binding site significantly reduced phosphorylationbeen shown to be major targets of TrkA in sympathetic
of Akt by TrkB, while mutation of either the PLC-g1 orneurons (Kaplan and Miller, 2000). To examine ERK acti-
SNT site alone had no effect. Stimulation of the TrkBvation, infected neurons were exposed to neurotrophin
Shc2/PLC-g12 receptor induced Akt phosphorylationfor 10 min, and the lysates were then probed with a
equivalent to or, in some instances, slightly lower thanphosphorylation and activation-specific ERK antibody
stimulation by TrkB Shc2. When both the Shc and PLC-(Figure 3A). Both ERK isoforms were robustly phosphor-
g1 binding sites were mutated, Akt phosphorylation wasylated upon stimulation of either endogenous TrkA or
still considerably higher than that seen in control neu-ectopically expressed TrkB (Figure 3A). Furthermore,
rons or in neurons expressing kinase dead TrkB (Figuresimilar levels of ERK phosphorylation were induced by 3B). Thus, we observed that TrkB stimulates Akt as effi-
both TrkA and TrkB activation after 24 hr (data not ciently as TrkA. Furthermore, there are multiple path-
shown). Disruption of the Shc binding site in TrkB re- ways by which Akt stimulation is achieved; signaling via
duced ERK phosphorylation by approximately half, the Shc binding site plays a major role in activating Akt,
whereas mutation of the PLC-g1 binding site or SNT but a second unidentified pathway is also important.
activation site had no apparent effect on ERK phosphor- It has recently been shown that TrkA-mediated stimu-
ylation. Combined mutation of both the Shc and PLC- lation of both ERKs and Akt is, at least in part, mediated
g1 binding sites resulted in a further reduction of ERK via Ras in sympathetic neurons (Mazzoni et al., 1999).
phosphorylation by TrkB, although a low level of phos- To determine whether the same was true for TrkB, we
phorylation was still detected relative to control neurons coinfected neurons with each of the different TrkB vi-
or to neurons transduced with kinase dead TrkB (Figure ruses in combination with an adenovirus encoding domi-
3A). Thus, it appears that the Shc binding site is respon- nant-negative Ras (DN Ras, N17 mutant) and assessed
sible for full activation of ERK by TrkB in sympathetic BDNF-mediated stimulation of downstream signaling
neurons, with the PLC-g1 binding site contributing to a pathways (Figure 3C). As for TrkA, the majority of TrkB-
lesser extent, and a third unidentified pathway contribut- mediated activation of ERKs was dependent on Ras
ing a minor level. (Figure 3C). This was true for each of the mutants exam-
ined. Akt phosphorylation induced by both TrkA andWe also examined activation of the serine/threonine
TrkB Survival and Axon Growth Signals
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Figure 4. TrkB Mediates Survival of Sympa-
thetic Neurons
Sympathetic neurons cultured for 4 days
were infected overnight with WT TrkB ade-
novirus. Forty-eight hours later, NGF was
washed out, and cells were fed with medium
alone (0), 10 ng/ml NGF, or BDNF (at concen-
trations as indicated) for an additional 48 hr.
Cell viability was analyzed by incubating cells
with the mitochondrial dye MTT for 3 hr. Mito-
chondrial activity was then assessed visually
(A) or by quantitation of colorimetric conver-
sion (B and C).
(A) Visual representation of neuronal survival.
TrkB-infected cells maintained in BDNF (50
ng/ml; middle panel) converted MTT dye as
efficiently as NGF-treated cells (top panel),
whereas untreated cells did not show any
MTT conversion (bottom panel). Scale bar 5
200 mm.
(B) Enhanced survival of sympathetic neu-
rons in BDNF with increasing levels of TrkB
infection. Cells were infected with increasing
MOI of WT TrkB and treated with 50 ng/ml
BDNF for 48 hr. Quantitation of MTT conver-
sion is plotted as a function of infection level. Two hundred MOI WT TrkB induced full survival, equivalent to that obtained with 10 ng/ml
NGF. Bars represent average (6SEM) for three experiments repeated in triplicate.
(C) Dose response curve for survival of TrkB-expressing neurons in increasing concentrations of BDNF. Cells infected with 200 MOI TrkB
were maintained in varying concentrations of BDNF and assessed for cell viability by MTT assay. Optimal survival was achieved with 25 ng/
ml BDNF. Bar represents average (6SEM) for three experiments repeated in triplicate.
TrkB was also significantly but not completely reduced TrkB (Figure 5A). In contrast, TrkB Shc2 only maintained
survival 18% above the survival seen without neuro-by Ras inactivation, suggesting that additional Ras-
independent pathways are involved in Akt activation in trophin. Coincident mutation of both the PLC-g1 and
Shc sites (TrkB Shc2/PLC-g1) reduced survival to zero,sympathetic neurons.
suggesting that the Shc association site is responsible
for the majority of TrkB-mediated survival, while the
TrkB Supports the Survival of Sympathetic Neurons PLC-g1 association site plays a minor role. Kinase dead
Having confirmed that the TrkB proteins are expressed TrkB did not support survival of sympathetic neurons,
well in sympathetic neurons and signaling through the as expected.
expected pathways, we assessed their ability to pro-
mote the survival of sympathetic neurons by MTT assay.
Multiple Signal Transduction Pathways ContributeBoth BDNF, acting through ectopically expressed TrkB,
to TrkB-Mediated Survivaland NGF, acting through endogenously expressed TrkA,
We next determined how the Shc association site medi-maintained neuronal survival (Figure 4A). To quantitate
ates the majority of TrkB-mediated survival in sympa-this survival effect, neurons were infected with varying
thetic neurons. The Shc site is largely responsible forMOIs of WT TrkB, exposed to 50 ng/ml BDNF, and sur-
activation of both ERK and Akt kinases by TrkB (Figurevival assessed using MTT assays (Figure 4B). Survival
3) and of PI3-kinase activity by TrkA (Ashcroft et al.,increased progressively as cells were treated with in-
1999). To determine whether the ERK or Akt signalingcreasing amounts of virus, corresponding with increas-
pathways are necessary for TrkB-mediated survival ofing levels of TrkB expression (data not shown). Two
sympathetic neurons, we used PD 98059, a selectivehundred MOI of WT TrkB resulted in 100% survival rela-
inhibitor of MEK, the kinase directly upstream of thetive to 10 ng/ml NGF, a concentration that we have
ERKs, and LY 294002, a selective inhibitor of PI3-kinase,previously demonstrated to be optimal for survival (Belli-
the upstream activator of Akt. Western blot analysis withveau et al., 1997). To determine the concentration de-
anti-phospho-ERK or anti-phospho-Akt confirmed thatpendence of this effect, neurons were infected with 200
PD 98059 suppressed ERK but not Akt activity, and LYMOI of WT TrkB and exposed to different BDNF concen-
294002 suppressed Akt but not ERK activity (Figure 5B).trations. Neuronal survival attained maximal levels at 25
We next analyzed the effects of blocking these pathwaysng/ml BDNF (Figure 4C). Thus, we performed all further
on both TrkA- and TrkB-mediated survival. As we haveexperiments using 200 MOI of virus and 25 ng/ml BDNF.
previously reported (Mazzoni et al., 1999; Vaillant et al.,
1999), inhibition of MEK with PD 98059 had little effect on
TrkA-mediated survival, whereas inhibition of PI3-kinaseThe SHC Site Is the Primary Mediator
of TrkB-Induced Survival with LY 294002 blocked survival in a dose-dependent
fashion (Figure 5C). Similar to TrkA-dependent survival,To determine the sites on TrkB responsible for survival,
we assayed the relative ability of wild-type and mutant LY 294002 also dramatically reduced TrkB-dependent
survival (Figure 5D). In contrast, however, inhibiting MEKTrkB to induce survival. Sister cultures expressing TrkB
viruses were treated with BDNF for 2 days. TrkB PLC- with PD 98059 also decreased TrkB-dependent survival;
75 mM PD 98059 reduced survival to 14% while 100 mMg12 and TrkB DKFG supported survival as well as WT
Neuron
270
Figure 5. TrkB-Induced Survival of Sympa-
thetic Neurons Is Mediated Primarily by the
Shc Binding Site via Both the PI3-Kinase and
MEK Pathways
Sympathetic neurons were infected overnight
with 200 MOI of adenoviruses expressing ei-
ther WT TrkB or the different TrkB receptor
mutants. After 48 hr, NGF was washed out,
and cells were treated with medium alone (0),
10 ng/ml NGF, or 25 ng/ml BDNF. In addition,
some wells were treated with PD 98059 or
LY 294002 in combination with either NGF or
BDNF (B±D). After 48 hr, survival was quanti-
tated by MTT assays. Percent survival is ex-
pressed relative to 10 ng/ml NGF (100%).
(A) Survival by the different TrkB receptor mu-
tants. Whereas WT TrkB supports survival in
25 ng/ml BDNF equivalently to 10 ng/ml NGF,
TrkB Shc2 supports only 18% survival and
TrkB Shc2/PLC-g12 supports virtually no
survival. Asterisk designates a significant dif-
ference relative to survival maintained by WT
TrkB (p , 0.005, t test); Double asterisk desig-
nates a significant difference relative to sur-
vival maintained by kinase dead TrkB (p ,
0.005, t test).
(B) Confirmation of biochemical specificity of
pharmacological inhibitors. Cells were washed
free of NGF and stimulated for 10 min with
100 ng/ml BDNF alone or 100 ng/ml BDNF in
combination with different concentrations of
either PD 98059 or LY 294002. Fifty micro-
grams of cell lysate was analyzed by Western
blotting for activation of the MEK pathway
using phospho-ERK antibody, and activation
of the PI3-kinase pathway using phospho-Akt
antibody. PD 98059 specifically blocked ERK
phosphorylation, whereas LY 294002 specifi-
cally blocked Akt phosphorylation. The lower panel shows the same blot reprobed with an antibody recognizing total ERK1 protein.
(C and D) Cells maintained under different treatments for 48 hr were assessed for survival using MTT assays. Percent survival is expressed
relative to 10 ng/ml NGF (100%). Survival of cells maintained in NGF (C) was not affected by inhibition of MEK using PD 98059, whereas
inhibition of PI3-kinase using LY 294002 reduced survival to 29%. Conversely, survival of BDNF-supported cells (D) was reduced to 14% by
MEK inhibition and to 2% by PI3-kinase inhibition. Bars represent average (6SEM) for three experiments repeated in triplicate. Asterisk
designates a significant difference relative to survival maintained by 10 ng/ml NGF (C) or 25 ng/ml BDNF (D) (p , 0.05, t test).
LY 294002 reduced survival to 2%. These data indicate NGF was added to the medium in one of the side com-
partments, and 25 ng/ml BDNF into the other. The cen-that the PI3-kinase and MEK kinase pathways work co-
operatively in promoting neuronal survival in response tral compartment contained 10 ng/ml NGF throughout
the experiment to maintain neuronal survival. Axon elon-to TrkB activation, whereas MEK activity is dispensable
for TrkA-mediated survival. gation into both compartments was then measured over
the subsequent 3 days, where the longest axon in each
track of each side compartment (16/side) was recorded.
BDNF successfully promoted axon outgrowth of TrkB-TrkB Mediates Axon Outgrowth
expressing sympathetic neurons in Campenot culturesof Sympathetic Neurons
(Figure 6B). Growth was less robust into BDNF than intoWe next examined the mechanisms underlying Trk-
NGF, likely because adenoviral infection was observedmediated promotion of axon outgrowth in sympathetic
to be much less efficient in compartmented culturesneurons, using the same TrkB mutants. Since some of
compared to mass cultures, resulting in lower numbersthese receptor mutants do not support survival, we per-
of infected cells and, in all probability, lower levels offormed this analysis in compartmented Campenot cham-
TrkB expression per infected neuron. Nonetheless,bers (Campenot, 1994), a system that allowed us to disso-
BDNF promoted axon growth at a constant rate in WTciate survival from growth (Figure 6A). Neurons were
TrkB-infected cultures, although the rate was slowerplated in the central compartment of Campenot cham-
than that for NGF-mediated growth into the other sidebers, and axons were encouraged to grow into side
compartment (15 m/hr versus 60 m/hr) (Figure 6C). Wecompartments by the addition of 10 ng/ml NGF in both
also found that growth into BDNF was quite heteroge-center and side compartments. After cultures were es-
neous, again likely due to heterogeneity in viral infection.tablished for 5±6 days, cells were infected with adenovi-
We therefore plotted the data for these and subsequentruses expressing WT TrkB or TrkB mutants, and 2 days
experiments as a distribution plot. We then demon-later, any axons in the side compartments were washed
away (Campenot, 1994). After this axotomy, 10 ng/ml strated the specificity of this BDNF-mediated growth
TrkB Survival and Axon Growth Signals
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Figure 6. TrkB Promotes BDNF-Dependent
Neurite Outgrowth in Sympathetic Neurons
(A) Schematic representation of a compart-
mented Campenot chamber. Cell bodies are
plated in and restricted to the central cham-
ber while axons can grow into side chambers
when appropriate growth cues are present
(e.g., NGF). The fluid environment of each
chamber is isolated from the other chambers.
Thus, survival can be maintained by including
NGF in the center compartment without af-
fecting axon outgrowth in the sides. Axons
in side compartments grow between tracks
scratched into the culture dish in a relatively
straight trajectory, facilitating measurements
of axon elongation.
(B) Comparison of rhodamine phalloidin±
stained axons from WT TrkB-expressing cul-
tures grown into 25 ng/ml BDNF versus 10
ng/ml NGF. BDNF promoted outgrowth of
healthy axons, though this growth was less
dense than that seen into NGF. Scale bar 5
100 mm.
(C) Rate of axon growth in BDNF. After infec-
tion, existing axons were washed away and
regrowth was measured daily over 3 days. Neurites grew at a linear rate of z15 mm/hr. Average growth (6SEM) is plotted.
(D) Pooled distribution plots of maximal growth measurements after 72 hr. Data was pooled from measurements taken from every track in
each of 3 different dishes. Control growth in NGF (left panel) is compared to WT TrkB-mediated or kinase dead TrkB-mediated growth into
BDNF (center and left panels, respectively). WT TrkB but not kinase dead TrkB promoted growth into BDNF.
response by infecting neurons with virus expressing ki- TrkB-Mediated Axon Outgrowth Is Dependent
nase dead TrkB. The axons of neurons expressing wild- on Signals from Both the MEK
type but not kinase dead TrkB extended into side com- and PI3-Kinase Pathways
partments containing BDNF (Figure 6D), confirming that To further define the downstream signaling cascades
this event is indeed mediated by active TrkB. involved in TrkB-mediated axon outgrowth, we tested
the effects of locally inhibiting either MEK or PI3-kinase
The SHC-Association Site of TrkB Is a Major on BDNF-mediated axon outgrowth. Compartmented
Regulator of Axon Outgrowth cultures were infected with WT TrkB and analyzed as
Having established that TrkB promotes local axon described above. However, following axotomy, one side
growth into BDNF, we then determined the signaling compartment was supplemented with BDNF alone,
pathways underlying this local growth promotion. Spe- while the other side was treated with BDNF in combina-
cifically, neurons in Campenot cultures were infected tion with the PI3-kinase inhibitor LY 294002 or the MEK
with each of the different TrkB mutants, and their ability inhibitors PD 98059 or U0126. We then assessed the
to mediate BDNF-dependent growth was assessed at effects of the different inhibitors on BDNF-mediated
4 days following axotomy. Results of this analysis are axon outgrowth in TrkB-expressing Campenot cultures.
presented in three ways: as the average length of growth Inhibition of PI3-kinase with LY 294002 dramatically in-
mediated by the different receptor mutants (Figure 7A), hibited local axon outgrowth into medium containing
visually by a representative image of growth for each of BDNF (Figure 8A). Similarly, inhibition of MEK using ei-
the mutants (Figure 7B), and as distribution plots of the ther PD 98059 or U0126 largely blocked axon outgrowth
growth promoted by each of the TrkB mutants (Figure into BDNF (Figure 8A). Residual growth in all cases ap-
7C). These analyses demonstrated that mutation of ei- proximated or was less than that seen with the TrkB
ther the PLC-g1 or SNT binding sites in TrkB had no Shc2 or TrkB Shc2/PLC-g12 receptors (Figure 5). In all
effect on TrkB-mediated growth. In contrast, the TrkB cases, growth on the control side into BDNF alone was
Shc2 receptor was significantly less effective at promot-
normal, demonstrating that the inhibitors antagonizeding local axon outgrowth than was WT TrkB; fewer TrkB
axon outgrowth by locally inhibiting signaling pathways.Shc2 axons grew into BDNF and those that did grow
Furthermore, treatment with DMSO vehicle alone hadwere quite short and often started to degenerate after
no effects on axon outgrowth (data not shown). Thus,several days in BDNF. The TrkB Shc2/PLC-g12 receptor
axon elongation into BDNF mediated by TrkB appearsyielded a profile similar to that seen with TrkB Shc2,
to require both the MEK and PI3-kinase pathways.confirming that the PLC-g1 activation site is of little or
We performed two control experiments to confirm thatno consequence to axon outgrowth. Even in the absence
treatment of side compartments with these pharmaco-of both the Shc and PLC-g1 association sites, however,
logical inhibitors did not retrogradely disrupt signalingthe TrkB receptor maintained some ability to promote
in the center compartment, thereby compromising celllocal axon outgrowth in comparison with the kinase
viability. First, we stimulated uninfected cultures withdead receptor, although this growth was not well main-
NGF on one side and NGF in combination with LYtained. Thus, the Shc binding site of TrkB is the major
294002, PD 98059, or U0126 on the other side for 30mediator of local axon outgrowth in sympathetic neu-
min, and then lysed the two sides separately, and werons, although a second as yet undefined site appears
to also play a role. also lysed the central cell body compartment. Lysates
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Figure 7. The Majority of TrkB-Mediated Axon Growth Is Mediated by the Shc Site
Cells were infected with adenovirus expressing WT TrkB or the different TrkB receptor mutants. Forty-eight hours later, existing axons were
washed out and axon growth into 25 ng/ml BDNF was measured over 96 hr. After 96 hr, the length of the longest axon in each track was
recorded, and the results from six different dishes were pooled for each mutant.
(A) To show relative growth ability, the average growth over 96 hr was determined for each of the TrkB mutants and plotted. Both TrkB Shc2
and TrkB Shc2/PLC-g12 were severely compromised in their ability to promote axon outgrowth relative to WT TrkB. Asterisk designates
average growth significantly different from WT TrkB (p , 0.005, t test).
(B) Sample fields showing rhodamine phalloidin labeling of axon growth elicited by the different TrkB receptor mutants. Note the differences
in relative growth densities promoted by the different mutants.
(C) Pooled distribution plots of maximal growth measured for each of the different TrkB receptor mutants. Again, the TrkB Shc2 and TrkB
Shc2/PLC-g12 mutants show deficits in axon outgrowth, as seen by skewing of the distribution curve towards shorter or no neurites.
were analyzed by Western blotting for Akt phosphoryla- Discussion
tion as an indicator of PI3-kinase activity and ERK phos-
phorylation as an indicator of MEK activity. Each of the The signals required for neurotrophin-induced axonal
inhibitors blocked activation of the expected pathways growth of peripheral neurons and how the Trk receptors
only in the side compartment where applied, while not are coupled to both local growth and survival signals
affecting stimulation in the center or control side (Figure are not known. In this report, we describe how the TrkB
8B). The majority of ERK phosphorylation detected was receptor mediates local growth and survival in sympa-
in the side compartments, which contain only axons. thetic neurons. We show that (1) the Shc binding site
In the second experiment, we maintained uninfected, in TrkB is required for most of neurotrophin-mediated
established compartments for 3 days in the presence survival and local axon growth, (2) the PLC-g1 site plays
of NGF on one side and NGF in combination with LY a minor role in promoting cell survival and none in local
294002, PD 98059, or U0126 on the other side, and growth, (3) PI3-kinase and MEK activity are both re-
then assayed neurons for long-term cytotoxicity. We quired for survival and local axon growth, and (4) while
incubated cells with a mixture of two fluorescent dyes, TrkA uses only PI3-kinase activity to induce survival,
Calcein-AM, which enters into and is retained within live TrkB uses multiple signals.
We found that the Shc binding site in TrkB regulatescells, and ethidium homodimer, which incorporates into
accessible DNA of damaged cells. Cells in control cul- the majority of sympathetic neuron survival and local
axon growth (Figure 8D). In the absence of this site,tures treated without inhibitors were generally very
healthy, with low levels of dying cells (Figure 8C, top survival was reduced to 18% and growth reduced to
z30% as compared to wild type TrkB-expressing neu-panels). Furthermore, incubation with PD 98059, LY
294002, or U0126 in side compartments did not have rons. No other single mutation in Trk significantly af-
fected survival or growth in this manner. Mutation of theany toxic effects on cells treated with these compounds
(Figure 8C), suggesting that these inhibitors acted lo- PLC-g1 binding site in combination with the Shc site
completely suppressed survival but did not further re-cally and did not retrogradely affect signaling or survival
in central compartments. duce growth responses. Only two previous studies have
TrkB Survival and Axon Growth Signals
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Figure 8. BDNF-Mediated Local Axon Out-
growth Is Dependent on Both PI3-Kinase and
MEK Activity
(A) Pooled distribution plots of growth in the
presence of PI3-kinase or MEK inhibitors. Ax-
ons from cultures infected with adenovirus
expressing WT TrkB were removed 48 hr
postinfection and regrown into 25 ng/ml
BDNF alone on one side of the chamber and
25 ng/ml BDNF in combination with 50 mM
LY 294002, 50 mM PD 98059, or 50 mM U0126
on the other side. Growth in each track was
measured after 96 hr, and measurements
from six dishes pooled to produce the results
shown here. All three inhibitors significantly
reduced average growth (p , 0.005, t test)
relative to control growth in the presence of
25 ng/ml BDNF; LY 294002 reduced growth
to 17% 6 5% (SEM), PD 98059 reduced
growth to 21% 6 5% (SEM), and U0126 re-
duced average growth to 4% 6 1% (SEM).
(B) Biochemical specificity of the three phar-
macological inhibitors was demonstrated by
acutely stimulating cells such that the inhibi-
tor was present only in one side chamber and
then harvesting each of the three compart-
ments (two sides 1 center) independently.
Specifically, NGF was washed out, and cells
were restimulated for 30 min with 50 ng/ml
NGF in the center and on one side while 50
ng/ml NGF in combination with 50 mM LY
294002, 50 mM PD 98059, or 50 mM U0126
was placed on the other side. Total lysates
were then assessed by Western blot to probe
for phospho-Akt as an indicator of PI3-kinase
activity or phospho-ERK as an indicator of
MEK activity. The inhibitors acted specifically
and their action was limited to the compart-
ment in which they were present. Specifically,
inhibition of PI3-kinase activity can be seen
by comparing the reduced phospho-Akt lev-
els in LY 294002-treated side compartments
versus DMSO-treated or control side compartments. However, no difference is seen in phospho-Akt levels in central compartments isolated
from dishes where side compartments were treated with LY 294002 versus DMSO, indicating that inhibitors were not retrogradely trafficked.
Similarly, inhibition of MEK is seen by comparing reduced phospho-ERK levels in PD 98059- or U0126-treated side compartments versus
DMSO-treated and control side compartments. Phospho-ERK levels are unchanged in central compartments taken from PD 98059- or U0126-
treated dishes versus DMSO-treated dishes. Notably, phospho-ERK levels were found to be low in central compartments of all dishes.
(C) Cell viability in the presence of the pharmacological inhibitors was assayed by a fluorescent live/dead assay. After maintaining established
cultures in the presence of 10 ng/ml NGF in the center and one of the side compartments and 10 ng/ml NGF in combination with 50 mM LY
294002, 50 mM PD 98059, or 50 mM U0126 on the other side for 3 days, cells were incubated with Calcein-AM to label live cells and ethidium
homodimer to label dead cells. As shown, none of the pharmacological inhibitors induced noticeable cell toxicity. Scale bar 5 150 mm.
(D) Schematic diagram indicating TrkB-activated signaling pathways important for neuronal survival and axon growth.
been able to ask similar questions about Trk signaling There have been few studies examining the role of
Trk signaling pathways in the promotion and regulationin neurons. Minichiello and colleagues (1998) reported
that in TrkBShc2/Shc2 mice, the Shc site controlled a small of axonal growth. Ming and colleagues (1999) examined
this issue using dissociated Xenopus spinal culturesportion of BDNF-dependent survival (25% loss in the
vestibular ganglion and no loss of BDNF-dependent no- from day-old embryos following blastomere injection
with mRNA for wild-type or mutant Trk isoforms. Onedose neurons), and the majority of NT-4-dependent sur-
vival in vivo. The Shc site was also essential for the conclusion from this study was that PLC-g activation
was essential for axon elongation. Our results usingsurvival in culture of nodose neurons in response to
either BDNF or NT-4. Together with the data presented mammalian sympathetic neurons are very different. The
TrkB PLC-g12 mutant, which was defective in activatinghere, these results suggest that TrkB mediates survival
largely via signaling through the Shc binding site. The PLC-g1 as assessed by tyrosine phosphorylation, dis-
played no deficits in axon elongation in sympatheticdiscrepancy between in vivo and in vitro data for BDNF-
dependent neuronal populations may arise because, in neurons. Furthermore, growth promoted by TrkB encod-
ing both Shc and PLC-g1 site mutations was no worsevivo, other growth factors may collaborate with BDNF-
bound TrkB Shc2 to compensate for the decrease in than by TrkB encoding only the Shc site mutation, further
confirming that the PLC-g1 site plays no role in axonTrkB signaling through this site. As BDNF is a better
ligand than NT-4 for TrkB Shc2 (Minichiello et al., 1998), growth in our cultures. Ming et al. also concluded that
the PLC-g and PI3-kinase sites are both essential forperhaps BDNF-dependent populations are better able
to benefit from such compensation in vivo. local growth cone turning responses in Xenopus spinal
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neurons. Conversely, we find that the Shc site is the axonal elongation. ERKs also phosphorylate neurofilament
most important for mediating local axon growth in sym- proteins (Veeranna et al., 1998). Similarly, PI3-kinase
pathetic neurons. While growth cone guidance may regulates or associates with a number of cytoskeletal
share similar mechanisms with axon elongation and can proteins, including actin (Rodriguez-Viciana et al., 1997),
be considered a form of very localized growth promo- tubulin (Kapeller et al., 1995), and actin-regulating pro-
tion, it is difficult to compare our data to that of Ming teins (Toker and Cantley, 1997). Our studies suggest
et al. for several reasons. First, the use of transient ex- that both the MEK/ERK and PI3-kinase pathways are
pression by mRNA injections in the latter report pre- ideally positioned to regulate local growth events rang-
vented biochemical confirmation that the neurons ex- ing from the directionality of growth cone extension to
pressing Trk mutants or treated with PI3-kinase and axon elongation itself.
PLC-g inhibitors were indeed defective in transmitting Studies reported here also demonstrate that the activ-
neurotrophin signals. Second, the Trk mutant used in ities of PI3-kinase and to a lesser extent MEK are in-
that study to eliminate NGF-mediated PI3-kinase signals volved in regulating TrkB-induced sympathetic neuron
has been shown to be fully competent to activate PI3- survival. Evidence for the role of the PI3-kinase/Akt path-
kinase activity (Baxter et al., 1995). These contrasting way in NGF-mediated survival of peripheral neurons is
results may also reflect possible differences in axon well documented (Crowder and Freeman, 1998; Klesse
growth signaling between Xenopus spinal neurons and and Parada, 1998; Mazzoni et al., 1999; Vaillant et al.,
mammalian sympathetic neurons. Thus, our data, com- 1999). PI3-kinase/Akt regulates survival by inhibiting the
bining genetic and biochemical analysis, provides con- activities of the cell death proteins Bad (Datta et al.,
clusive evidence that signaling through the Shc site me- 1997) and the transcription factor Forkhead (Brunet et
diates the majority of neurotrophin-dependent local al., 1999) in cerebellar neurons and by suppressing the
axon growth. JNK/p53 cell death pathway in sympathetic neurons
How does the Shc site mediate survival and axon (Mazzoni et al., 1999). In contrast to PI3-kinase/Akt, MEK
outgrowth? Whereas mutation of the Shc site clearly activity is not important for regulating NGF-dependent
eliminates Shc tyrosine phosphorylation, this mutation peripheral neuron survival (Creedon et al., 1996; Virdee
can effect other signaling processes such as FRS-2 and Tolkovsky, 1996; Klesse and Parada, 1998; Mazzoni
binding to Trk (Meakin et al., 1999). Thus, we cannot et al., 1999). However, MEK activity can mediate, to some
conclusively say that Shc itself is required for these extent, cell survival in neurotrophin-regulated neuronal
biological effects. However, we present data here show- systems, including the survival of cultured cerebellar
ing that the MEK/ERK and PI3-kinase/Akt pathways, granule neurons (Bonni et al., 1999) and retinal ganglion
both of which are likely dependent on Shc signaling cells (Meyer-Franke et al., 1998), and neuroprotection
through Ras (Stephens et al., 1994; Rodriguez-Viciana against camptothecin-induced death of cortical neurons
et al., 1994; Hallberg et al., 1998; Ashcroft et al., 1999), (Hetman et al., 1999) and CA-induced death of sympa-
are essential for survival and local growth. TrkB mutated thetic neurons (Anderson and Tolkovsky, 1999). In addi-
at the Shc site does retain a limited ability to stimulate tion, sympathetic neuronal survival promoted by acti-
axonal growth and induce ERK and Akt phosphorylation vated Ras occurs partly through the MEK/ERK pathway
in response to BDNF. This may reflect the ability of Trk (Mazzoni et al., 1999). MEK, together with Akt, may regu-
to use adaptor proteins other than Shc to stimulate these late survival by activating the transcription factor CREB,
events. For example, TrkA mutated at the Shc site can which is a critical regulator of NGF-mediated neuronal
activate ERK through the PLC-g1 site (Stephens et al., survival of sympathetic neurons (Riccio et al., 1999) and
1994). TrkA also can stimulate ERK activity indepen- of BDNF-mediated survival of cerebellar neurons (Bonni
dently of the Shc site via rAPS and SH2-B (Qian et al., et al., 1999).
1998), Akt via Gab1 (Korhonen et al., 1999), and neurito- In general, TrkA uses PI3-kinase activity to regulate
genesis in PC12 cells via SNT. Signaling proteins such cell survival, while TrkB uses both PI3-kinase and MEK.
as these whose activities are regulated independently TrkB thus appears to function in a more ªflexibleº man-
of the Shc site may account for the residual 30% of ner, using multiple signaling pathways to control specific
axonal growth observed in neurons expressing TrkB Shc effects. TrkB may require such signaling flexibility to
site mutants. converge and synergize with many divergent survival
No report has described the signals involved in pro- cues that CNS neurons are exposed to. Whether such
moting local axon outgrowth. NGF promotes locally in- distinctions between TrkA and TrkB generalize to other
creased axonal growth in culture (Campenot, 1994) and
neuronal responses such as growth, phenotypic modu-increased target innervation in vivo (Edwards et al.,
lation, or ongoing plasticity remains to be determined.1989; Albers et al., 1994; Miller et al., 1994; Patel et al.,
Nevertheless, it may well be that TrkA may only have to2000). Attempts to address the intracellular signaling
make use of a single signaling pathway such as PI3-mechanisms that regulate such local responses have
kinase to induce responses such as survival, suggestingused systems where global or local affects on growth
that TrkA and TrkB are fundamentally different in theircannot be distinguished, and where survival and growth
signaling capabilities.effects cannot be segregated. Here, using compart-
mented cultures, which overcome both of these con-
Experimental Proceduresfounding local issues (Campenot, 1994), we found that
local TrkB-mediated axon elongation was dependent on
Generation of Mutant TrkB Constructsboth PI3-kinase and MEK activity, as activated via the PCR-based site-directed mutagenesis was performed on a c-Myc-
Shc site. How do MEK and PI3-kinase promote local axo- tagged rat TrkB cDNA in Bluescript (pSK-TrkB; gift from P. Barker).
nal growth? The MEK/ERK pathway is well known to phos- PCR primers used to generate mutants were as follows: Y490F,
phorylate microtubule-associated proteins (MAPs), includ- 59-AACCCCCAGTTCTTCGGTATC-39 (sense) and 59-GATACCGAAG
ing Tau (Roder et al., 1993; Garcia Rocha and Avila, AACTGGGGGTT-39 (antisense); DKFG, 59-GACATTCCATGAAAGGCC
CAGCTTCC-39 (sense) and 59-GGCCTTTCATCCAATGTCTCGCCAAC1995), that regulate microtubule stability and control
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TTGAG-39 (antisense); and K538N, 59-GTGGCCGTGAACACGCTGA (NEB). Blots were incubated with secondary antibodies (Boehringer±
Mannheim) for 1 hr, and detection performed using ECL (Amersham).AGG-39 (sense) and 59-CCTTCAGCGTGTTCACGGCCAC-39 (anti-
sense). All antisense primers were used with an upstream primer Biochemical stimulations in Campenot cultures were carried out
with a few variations. All compartments were washed with NGF-flanking a unique NdeI site; sense primers were reacted with a
downstream primer surrounding a unique NruI site. To generate free medium for 4 hr. Cells were preincubated with different pharma-
cological inhibitors for 45 min prior to stimulation. Stimulation me-Y785F, an antisense primer of 59-TGATCACTAGCCTAGGATGTCCA
GGAACAGGGGCGACGC-39 was used with an upstream oligo con- dium was then added for 30 min at 378C. Individual compartments
were harvested in sample buffer (1.7% SDS, 0.08% glycerol, 0.013taining a unique BglII site.
g/ml DTT, bromophenol blue), boiled, and assayed. Lysates from
two dishes were pooled and separated on SDS±PAGE gels andGeneration of Recombinant Adenoviruses
analyzed as described above.TrkB constructs were excised from pSK-TrkB with BclI and cloned
into the BamHI site of pAdTR5F (Massie et al., 1998). Recombinant
Survival Assaysadenoviruses were generated, amplified, purified, and titered as
Cells were cultured in a 96-well dish and infected as described.described previously (Massie et al., 1995; Mazzoni et al., 1999).
Three days postinfection, NGF was washed out by four 1 hr washesAlthough viruses were under the control of a tet-responsive pro-
in medium. Cells were fed with Ultraculture containing the appro-moter (Massie et al., 1998), adequate expression levels were ob-
priate neurotrophic factor and/or pharmacological inhibitors. PDtained in sympathetic neurons for analysis without use of a tet trans-
98059 was replaced every 24 hr. Two days after treatment, cellactivator. The dominant-negative Ras virus has been previously
viability was assayed by MTT (Sigma) as described (Vaillant et al.,described (Mazzoni et al., 1999).
1999). Percent survival refers to the survival above baseline (0 ng/
ml NGF), relative to the survival supported by 10 ng/ml NGF (100%)Cell Culture and Infection
under experimental conditions. NGF (10 ng/ml) supports full survivalSympathetic neurons of the superior cervical ganglion (SCG) were
of SCG neurons (Belliveau et al., 1997). Experiments were performeddissected from P1 Sprague±Dawley rats and dissociated as de-
in triplicate and repeated at least 3 times.scribed previously (Ma et al., 1992). Neurons were cultured onto
collagen-coated 96-well plates (5000 cells/well) or 6-well plates
Measurement of Axon Elongation(80,000±100,000 cells/well) and maintained in Ultraculture medium
Two days postinfection, existing axons were axotomized as de-(BioWhittaker) supplemented with 100 U/ml penicillin, 100 mg/ml
scribed by Campenot (1992). Anti-NGF (Sigma) was used to neutral-streptomycin, 2 mM glutamine, 2% rat serum (Harlan), 7 mM cytosine
ize residual NGF. Medium containing the appropriate neurotrophinsarabinoside (CA), and 10 ng/ml NGF (Cedarlane Labs). After 4 days,
and/or pharmacological inhibitors was added back to the side com-cultures were infected overnight in DMEM (GIBCO) with 10% FBS
partments and regrowth measured. Axon extension was measuredand 10 ng/ml NGF, a medium which increased infection efficiency.
in each track (16/side compartment) of each dish with the use of anAfter infection, cells were again maintained in Ultraculture (serum-
ocular micrometer and inverted phase-contrast microscope (Ziess).free, CA-free) with 10 ng/ml NGF for 2 days prior to analysis.
Experiments were performed in duplicate and repeated 3 times.Campenot cultures were prepared as described by Campenot
(1994). SCG neurons were plated into central compartments (0.75
Acknowledgmentsganglion/dish). Culture medium was similar to that used for mass
cultures, with the supplement of methyl cellulose (Sigma), to 3.5 g/l.
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